Home / News / India /  Will provide coronavirus vaccine free of cost once ready: Tamil Nadu CM Palaniswami

Will provide coronavirus vaccine free of cost once ready: Tamil Nadu CM Palaniswami

Tamil Nadu Chief Minister Edapaddi K Palaniswami.Premium
Tamil Nadu Chief Minister Edapaddi K Palaniswami.

  • The Tami Nadu government's decision came ahead of next year’s Assembly elections on 7 October
  • Earlier today, FM Sitharaman also announced that the BJP's vision document included the promise of free of cost Covid vaccination for the people of Bihar while releasing the party's manifesto for the state polls

Tami Nadu Chief Minister Edappadi K. Palaniswami on Thursday announced that once the coronavirus vaccine is ready, it will be provided to all people of the state free of cost. The Tami Nadu government's decision came ahead of next year’s Assembly elections on 7 October.

The Tami Nadu CM's "free Covid-19 vaccine" promise came after the BJP's "free coronavirus vaccination for all" promise in Bihar ahead of the state polls.

Union Finance Minister Nirmala Sitharaman had today released the BJP's manifesto for the Bihar assembly elections, which promised free Covid-19 vaccine once it has been cleared by the ICMR.

Speaking about the Covid-19 vaccine, Sitharaman said that the country has reached a point where it is on the verge of producing three vaccines after different stages of trial.

"When we reach the stage where scientists give clearance for large-scale production of the vaccine, we will make it available to the people of Bihar free of cost," the Union Finance Minister added.

Covid vaccine may be ready by December

We all are waiting with bated breath for a "safe and effective" vaccine against the deadly virus. The central government expects that a vaccine will be ready for sale in India as early as December if clinical trials are successful, as per a Mint report.

Currently, three vaccine candidates are at different phases of trial in the country. Two homegrown vaccine candidates -- Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila have already started the phase II clinical trial.

The other vaccine candidate -- Covishield -- developed by the University of Oxford has recently commenced the phase III clinical trial in India. Vaccine maker AstraZeneca has signed a deal with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and low-income countries.

"We're expecting that early next year we should have vaccine in the country from maybe more than one source. Our expert groups are formulating strategies to plan on how to roll out the distribution of the vaccine in the country," health minister Harsh Vardhan said earlier.

Meanwhile, India today reported 55,838 fresh Covid-19 cases and 702 fatalities in a span of 24 hours. With this, the overall infections rose to 77,06,946 while the death toll surged to 1,16,616.

Now, the active coronavirus cases in the country have remained below 10% of the total caseload for the last three days suggesting that only 1 in 10 cases are active coronavirus patients, the Union Health Ministry said today. The daily positivity rate has also been maintained at less than 5% over the past three days. “There are 7,15,812 active cases of coronavirus infection in the country which comprises 9.29 per cent of the total caseload," the data stated. As many as 68,74,518 people have been recovered with 79,415 new discharges.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout